LQDA compared with IRD: revenue, margins and what each company keeps, and the suppliers and customers both name

LQDALiquidia Corp

Mkt capRevenueRevenue

IRDOpus Genetics, Inc.

Mkt capRevenueRevenue

Compare

LQDALiquidia Corp

IRDOpus Genetics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LQDA

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±11.9%▼−10.52%×0.88

May 11 '26±12.0%▲+25.60%×2.13

Q1 FY26±13.8%▲+0.41%×0.03

Q3 FY25±30.8%▲+3.53%×0.11

IRD1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±41.2%▼−1.59%×0.04

= impliedLQDA realized, solidIRD realized, hatchedOne scale, both sides: full bar = 42%× = |realized| ÷ impliedSource: market data

LQDALiquidia Corp

44.44▼−0.12%· post 44.41

Mkt cap$4.5BRevenue$172MQ2 FY26Revenue$158MFY25

IRDOpus Genetics, Inc.

4.17▲+4.11%· post 4.17

ClosedNov 6 '26

Mkt cap$347.8MRevenue$755,000Q2 FY26Revenue$14MFY25

Compare

ClosedNov 6 '26

LQDALiquidia Corp

IRDOpus Genetics, Inc.

44.44▼−0.12%post 44.41

Price

4.17▲+4.11%post 4.17

$4.5B

Mkt cap

$347.8M

Q2 FY26$172M

Revenue

$755,000Q2 FY26

FY25$158M

Revenue

$14MFY25

LQDA44.44▼−0.12%vsIRD4.17▲+4.11%ClosedNov 6 '26